BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27273680)

  • 1. Expression of Bcl-2 19-kDa interacting protein 3 predicts prognosis after ampullary carcinoma resection.
    Fujimoto T; Ohtsuka T; Date K; Kimura H; Matsunaga T; Mori Y; Miyasaka Y; Mochidome N; Oda Y; Nakamura M
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):489-96. PubMed ID: 27273680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
    Sakabe R; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakashima A; Ohge H; Sueda T; Hiyama E
    Ann Surg Oncol; 2012 Sep; 19(9):3072-80. PubMed ID: 22322954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.
    Oba A; Ban D; Kirimura S; Akahoshi K; Mitsunori Y; Matsumura S; Ochiai T; Kudo A; Tanaka S; Minoru T
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):480-8. PubMed ID: 27247050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
    Hosoda K; Fukushima K; Shimizu A; Motoyama H; Kubota K; Notake T; Sugenoya S; Hayashi H; Yasukawa K; Kobayashi R; Soejima Y
    Oncology; 2021; 99(11):703-712. PubMed ID: 34515195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thymidylate synthase in cancer of the ampulla of Vater.
    Ajiki T; Habara K; Kamigaki T; Nakamura T; Fujino Y; Suzuki Y; Takeyama Y; Kuroda Y; Nakamura T
    Oncol Rep; 2001; 8(4):759-62. PubMed ID: 11410778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intratumoral thymidylate synthase expression on prognosis after surgical resection for ampullary carcinoma.
    Kato Y; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Hiyama E; Sueda T
    J Surg Oncol; 2011 Jun; 103(7):663-8. PubMed ID: 21360535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
    Bogoevski D; Chayeb H; Cataldegirmen G; Schurr PG; Kaifi JT; Mann O; Yekebas EF; Izbicki JR
    J Gastrointest Surg; 2008 Nov; 12(11):1830-7; discussion 1837-8. PubMed ID: 18791769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sueda T
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S646-55. PubMed ID: 22086444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
    Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
    Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.
    Shoji H; Morizane C; Hiraoka N; Kondo S; Ueno H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
    Jpn J Clin Oncol; 2014 Apr; 44(4):324-30. PubMed ID: 24482413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.
    Colussi O; Voron T; Pozet A; Hammel P; Sauvanet A; Bachet JB; Vaillant JC; Rougier P; Nordlinger B; Berger A; Coriat R; Dousset B; Malka D; André T; Paye F; Aparicio T; Locher C; Cojean Zeleck D; Tchinou L; Bonnetain F; Taieb J
    Eur J Surg Oncol; 2015 Apr; 41(4):520-6. PubMed ID: 25680954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
    Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
    Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.
    Kawabata Y; Nishi T; Kidani A; Tajima Y
    Pancreas; 2015 Aug; 44(6):937-44. PubMed ID: 25906447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
    J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
    Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
    Sudo T; Murakami Y; Uemura K; Hayashidani Y; Hashimoto Y; Ohge H; Shimamoto F; Sueda T
    Dig Dis Sci; 2008 Aug; 53(8):2281-6. PubMed ID: 18095164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lymph node metastasis on survival in patients with pathological T1 carcinoma of the ampulla of Vater.
    Terasawa H; Uchiyama K; Tani M; Kawai M; Tsuji T; Tabuse K; Kobayashi Y; Taniguchi K; Yamaue H
    J Gastrointest Surg; 2006 Jun; 10(6):823-8. PubMed ID: 16769538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
    Harada N; Shirabe K; Yoshizumi T; Ikegami T; Uchiyama H; Soejima Y; Yamashita Y; Saeki H; Oki E; Kawanaka H; Morita M; Ikeda T; Matsuura H; Okadome K; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):539-48. PubMed ID: 24693682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.